MCGLYNN MARGARET G 4
4 · AMICUS THERAPEUTICS, INC. · Filed Mar 6, 2024
Insider Transaction Report
Form 4
MCGLYNN MARGARET G
Director
Transactions
- Exercise/Conversion
Stock Options (right to buy)
2024-03-04−7,500→ 7,500 totalExercise: $2.80Exp: 2024-06-12→ Common Stock (7,500 underlying) - Exercise/Conversion
Stock Options (right to buy)
2024-03-05−7,500→ 0 totalExercise: $2.80Exp: 2024-06-12→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2024-03-04$2.80/sh+7,500$21,000→ 66,789 total - Exercise/Conversion
Common Stock
2024-03-05$2.80/sh+7,500$21,000→ 66,789 total - Sale
Common Stock
2024-03-05$13.40/sh−7,500$100,500→ 59,289 total - Sale
Common Stock
2024-03-04$13.29/sh−7,500$99,675→ 59,289 total
Footnotes (1)
- [F1]All of the options were fully vested and exercisable as of the transaction date.